Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox

Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox

Source: 
Forbes
snippet: 

Thursday, at a medical conference being hosted by the Michael J. Fox Foundation, a biotechnology company is presenting the first human data from a Parkinson’s drug that several of the world’s largest drug companies nearly abandoned.

The company, Denali Therapeutics, is run by a widely respected team that formerly worked at Genentech, the Roche unit, and it had one of the largest biotech initial public offerings of 2017. But the stock is down 16% from its IPO price.